Pharma Controversies Unpacked
Recent controversies in the pharmaceutical sector are making headlines, particularly surrounding the proposed Pfizer-Allergan merger, which critics argue is a tax evasion tactic. The discussion also highlights the fallout from companies like Valeant and Turing, where questionable pricing strategies have sparked outrage. Amidst calls for regulatory reforms, an intriguing question arises: could hedge funds hold the key to addressing these pricing issues?In this clip
From this podcast
Odd Lots
Episode 4: Can a Hedge Funder Cut Prescription Drug Costs?
Related Questions
What do you think about the pharmaceutical industry in the context of the episode Curing the Trust Problem with Mark Cuban and the clip Pharmaceutical Pricing Challenges, considering the episode Martin Shkreli Reveals How He Made His First $100 Million (#445) and the clip Corporate Personality Crisis?
I have a question about the episode Sam Harris: Trump, Pandemic, Twitter, Elon, Bret, IDW, Kanye, AI & UFOs | Lex Fridman Podcast #365 and the clip Pharmaceutical Transparency. Who funds pharmaceutical research, as discussed in the episode Dr. Mark Hyman: The Truth About Why Americans Are Getting Sicker | Ultimate Human | Ep. 115 and the clip Corporate Influence Exposed?